Logo image of HELE

HELEN OF TROY LTD (HELE) Stock Fundamental Analysis

USA - NASDAQ:HELE - BMG4388N1065 - Common Stock

22.9 USD
-0.32 (-1.38%)
Last: 9/19/2025, 10:17:25 AM
Fundamental Rating

3

Taking everything into account, HELE scores 3 out of 10 in our fundamental rating. HELE was compared to 63 industry peers in the Household Durables industry. HELE has a medium profitability rating, but doesn't score so well on its financial health evaluation. HELE is cheap, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

HELE had positive earnings in the past year.
In the past year HELE had a positive cash flow from operations.
In the past 5 years HELE has always been profitable.
In the past 5 years HELE always reported a positive cash flow from operatings.
HELE Yearly Net Income VS EBIT VS OCF VS FCFHELE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of -12.56%, HELE is doing worse than 85.71% of the companies in the same industry.
HELE has a Return On Equity of -27.14%. This is amonst the worse of the industry: HELE underperforms 85.71% of its industry peers.
HELE has a Return On Invested Capital (7.07%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for HELE is below the industry average of 10.52%.
Industry RankSector Rank
ROA -12.56%
ROE -27.14%
ROIC 7.07%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
HELE Yearly ROA, ROE, ROICHELE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

In the last couple of years the Profit Margin of HELE has declined.
HELE has a Operating Margin of 10.11%. This is comparable to the rest of the industry: HELE outperforms 57.14% of its industry peers.
HELE's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 47.59%, HELE belongs to the top of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of HELE has grown nicely.
Industry RankSector Rank
OM 10.11%
PM (TTM) N/A
GM 47.59%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
HELE Yearly Profit, Operating, Gross MarginsHELE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HELE is destroying value.
The number of shares outstanding for HELE has been reduced compared to 1 year ago.
The number of shares outstanding for HELE has been reduced compared to 5 years ago.
HELE has a worse debt/assets ratio than last year.
HELE Yearly Shares OutstandingHELE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
HELE Yearly Total Debt VS Total AssetsHELE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

HELE has an Altman-Z score of 1.77. This is a bad value and indicates that HELE is not financially healthy and even has some risk of bankruptcy.
HELE has a Altman-Z score of 1.77. This is in the lower half of the industry: HELE underperforms 71.43% of its industry peers.
HELE has a debt to FCF ratio of 7.78. This is a slightly negative value and a sign of low solvency as HELE would need 7.78 years to pay back of all of its debts.
HELE has a Debt to FCF ratio (7.78) which is in line with its industry peers.
A Debt/Equity ratio of 0.69 indicates that HELE is somewhat dependend on debt financing.
HELE has a Debt to Equity ratio of 0.69. This is in the lower half of the industry: HELE underperforms 65.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.78
Altman-Z 1.77
ROIC/WACC0.78
WACC9.01%
HELE Yearly LT Debt VS Equity VS FCFHELE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

2.3 Liquidity

HELE has a Current Ratio of 1.70. This is a normal value and indicates that HELE is financially healthy and should not expect problems in meeting its short term obligations.
HELE has a Current ratio of 1.70. This is in the lower half of the industry: HELE underperforms 66.67% of its industry peers.
HELE has a Quick Ratio of 1.70. This is a bad value and indicates that HELE is not financially healthy enough and could expect problems in meeting its short term obligations.
HELE's Quick ratio of 0.74 is in line compared to the rest of the industry. HELE outperforms 41.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 0.74
HELE Yearly Current Assets VS Current LiabilitesHELE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1

3. Growth

3.1 Past

The earnings per share for HELE have decreased strongly by -16.94% in the last year.
The Earnings Per Share has been decreasing by -4.99% on average over the past years.
HELE shows a decrease in Revenue. In the last year, the revenue decreased by -4.35%.
The Revenue has been growing slightly by 2.24% on average over the past years.
EPS 1Y (TTM)-16.94%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-58.59%
Revenue 1Y (TTM)-4.35%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-10.84%

3.2 Future

The Earnings Per Share is expected to decrease by -6.94% on average over the next years.
The Revenue is expected to grow by 1.02% on average over the next years.
EPS Next Y-35.91%
EPS Next 2Y-15.96%
EPS Next 3Y-6.94%
EPS Next 5YN/A
Revenue Next Year-7.51%
Revenue Next 2Y-2.34%
Revenue Next 3Y1.02%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HELE Yearly Revenue VS EstimatesHELE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B
HELE Yearly EPS VS EstimatesHELE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

7

4. Valuation

4.1 Price/Earnings Ratio

HELE is valuated cheaply with a Price/Earnings ratio of 3.46.
98.41% of the companies in the same industry are more expensive than HELE, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HELE to the average of the S&P500 Index (27.41), we can say HELE is valued rather cheaply.
HELE is valuated cheaply with a Price/Forward Earnings ratio of 4.50.
Based on the Price/Forward Earnings ratio, HELE is valued cheaply inside the industry as 96.83% of the companies are valued more expensively.
HELE is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 3.46
Fwd PE 4.5
HELE Price Earnings VS Forward Price EarningsHELE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HELE is valued cheaply inside the industry as 87.30% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 95.24% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.7
EV/EBITDA 5.67
HELE Per share dataHELE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

A cheap valuation may be justified as HELE's earnings are expected to decrease with -6.94% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-15.96%
EPS Next 3Y-6.94%

0

5. Dividend

5.1 Amount

HELE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HELEN OF TROY LTD

NASDAQ:HELE (9/19/2025, 10:17:25 AM)

22.9

-0.32 (-1.38%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)07-10 2025-07-10/bmo
Earnings (Next)10-01 2025-10-01/bmo
Inst Owners107.23%
Inst Owner Change-0.98%
Ins Owners0.73%
Ins Owner Change40.04%
Market Cap525.78M
Analysts74.55
Price Target28.05 (22.49%)
Short Float %14.56%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.77%
Min EPS beat(2)-52.71%
Max EPS beat(2)-4.82%
EPS beat(4)2
Avg EPS beat(4)-10.7%
Min EPS beat(4)-52.71%
Max EPS beat(4)13.41%
EPS beat(8)4
Avg EPS beat(8)-9.22%
EPS beat(12)8
Avg EPS beat(12)-3.77%
EPS beat(16)12
Avg EPS beat(16)1.48%
Revenue beat(2)0
Avg Revenue beat(2)-4.61%
Min Revenue beat(2)-7.92%
Max Revenue beat(2)-1.31%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-7.92%
Max Revenue beat(4)1.46%
Revenue beat(8)2
Avg Revenue beat(8)-2.43%
Revenue beat(12)4
Avg Revenue beat(12)-1.5%
Revenue beat(16)8
Avg Revenue beat(16)1.42%
PT rev (1m)0%
PT rev (3m)-57.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-55.2%
EPS NY rev (1m)-12.77%
EPS NY rev (3m)-23.66%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-12.07%
Revenue NY rev (1m)-1.37%
Revenue NY rev (3m)-6.79%
Valuation
Industry RankSector Rank
PE 3.46
Fwd PE 4.5
P/S 0.28
P/FCF 4.7
P/OCF 3.6
P/B 0.43
P/tB N/A
EV/EBITDA 5.67
EPS(TTM)6.62
EY28.91%
EPS(NY)5.09
Fwd EY22.21%
FCF(TTM)4.88
FCFY21.29%
OCF(TTM)6.37
OCFY27.81%
SpS81.12
BVpS53.47
TBVpS-4.37
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.56%
ROE -27.14%
ROCE 8.77%
ROIC 7.07%
ROICexc 7.15%
ROICexgc 19.06%
OM 10.11%
PM (TTM) N/A
GM 47.59%
FCFM 6.01%
ROA(3y)4.94%
ROA(5y)6.79%
ROE(3y)9.09%
ROE(5y)12.93%
ROIC(3y)7.78%
ROIC(5y)9.49%
ROICexc(3y)7.81%
ROICexc(5y)9.62%
ROICexgc(3y)23.08%
ROICexgc(5y)29.38%
ROCE(3y)9.64%
ROCE(5y)11.77%
ROICexcg growth 3Y-15.74%
ROICexcg growth 5Y-12.1%
ROICexc growth 3Y-13.74%
ROICexc growth 5Y-11.08%
OM growth 3Y-3.04%
OM growth 5Y-2.95%
PM growth 3Y-13.62%
PM growth 5Y-6.17%
GM growth 3Y3.79%
GM growth 5Y2.19%
F-Score3
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 7.78
Debt/EBITDA 3.49
Cap/Depr 62.02%
Cap/Sales 1.84%
Interest Coverage 250
Cash Conversion 60.04%
Profit Quality N/A
Current Ratio 1.7
Quick Ratio 0.74
Altman-Z 1.77
F-Score3
WACC9.01%
ROIC/WACC0.78
Cap/Depr(3y)172.35%
Cap/Depr(5y)199.35%
Cap/Sales(3y)3.95%
Cap/Sales(5y)4.01%
Profit Quality(3y)83.41%
Profit Quality(5y)72.63%
High Growth Momentum
Growth
EPS 1Y (TTM)-16.94%
EPS 3Y-16.48%
EPS 5Y-4.99%
EPS Q2Q%-58.59%
EPS Next Y-35.91%
EPS Next 2Y-15.96%
EPS Next 3Y-6.94%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.35%
Revenue growth 3Y-4.98%
Revenue growth 5Y2.24%
Sales Q2Q%-10.84%
Revenue Next Year-7.51%
Revenue Next 2Y-2.34%
Revenue Next 3Y1.02%
Revenue Next 5YN/A
EBIT growth 1Y-16.67%
EBIT growth 3Y-7.86%
EBIT growth 5Y-0.78%
EBIT Next Year-14.05%
EBIT Next 3Y1.78%
EBIT Next 5YN/A
FCF growth 1Y-56.46%
FCF growth 3Y9.8%
FCF growth 5Y-19.99%
OCF growth 1Y-60.23%
OCF growth 3Y-7.01%
OCF growth 5Y-16.04%